Skip to main content
OpenTrials
Completed

NCT Number: NCT00833573

National Survey on GERD Patients (Adults and Children)

To describe GERD digestive expression according to ages: - children (from 0 to 23 months) and (24 months and more)- adults (from 18 to 29 years old), (from 30 to 39 years old), (from 40 to 49 years old), (from 50 to 59 years old), (more than 60 years old)

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Abbaretz, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults : - Male or female > or = 18 years old - With at least one GERD typical clinical sign (pyrosis and / or acid regurgitations).- Not receiving any GERD treatment within the 3 previous months.
  • Children :- Male or female < 18 years old - With GERD digestive clinical signs during the consultation (receiving treatment or not)- Whose parents or legal guardian gave oral approval to the child participation in the survey.

Exclusion criteria

-

Treatment and study plan

Primary outcomes

  1. To describe GERD digestive expression according to ages: - children (from 0-23 months) and (24 months and more)- adults (from 18-29 years old), (from 30-39 years old), (from 40-49 years old), (from 50-59 years old), (more than 60 years old)

    Time frame: once

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Acronym: RGO à trav

Important dates

Study start
2009
Study completion
2009
First posted
Feb 2, 2009
Registry last updated
Nov 17, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.